Abstract

Introduction: Lung cancer is the leading cause of cancer death worldwide and in Vietnam. Among lung cancer cases, non-small cell lung cancer (NSCLC) accounts for approximately 85%. Most patients are diagnosed at the advanced stage, hence systemic therapy plays a crucial role to increase survival time. Targeted therapy is now the standard of care for NSCLC with TKIs sensitive mutations because of its efficacy and tolerability. The study of QoL in these groups of patients remains limited in Vietnam . Objectives : To evaluate the quality of life in patients with non-small cell lung cancer (NSCLC) being treated by targeted therapy and to determine the factors that affect the quality of life (QOL). Methodology: A descriptive study was conducted on 55 non-small cell lung cancer patients being treated at the Hue Central Hospital and the Hue University of Medicine and Pharmacy Hospital from 6/2021 to 8/2022. The EORTC QLQ-C30 was used to assess the quality of life. Evaluation of the quality of life by descriptive statistics. The linear regression test was used to determine the correlated factor. Results: The mean age of the group of patients was 66.6 ± 9.9.